Shareholder alert: robbins llp informs investors of class action against bioxcel therapeutics, inc. (btai)

San diego--(business wire)---- $btai #bioxceltherapeuticsinc--bioxcel therapeutics, inc. (btai) clinical trial failed to adhere to data integrity controls.

BTAI Ratings Summary

BTAI Quant Ranking